GB1577868A - Agent for protecting against renal failure - Google Patents

Agent for protecting against renal failure Download PDF

Info

Publication number
GB1577868A
GB1577868A GB14869/77A GB1486977A GB1577868A GB 1577868 A GB1577868 A GB 1577868A GB 14869/77 A GB14869/77 A GB 14869/77A GB 1486977 A GB1486977 A GB 1486977A GB 1577868 A GB1577868 A GB 1577868A
Authority
GB
United Kingdom
Prior art keywords
salt
glucaro
lactam
antibiotic
dideoxykanamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB14869/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of GB1577868A publication Critical patent/GB1577868A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
GB14869/77A 1976-04-16 1977-04-07 Agent for protecting against renal failure Expired GB1577868A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4238076A JPS52128232A (en) 1976-04-16 1976-04-16 Drugs for alleviating toxicity to kidneys

Publications (1)

Publication Number Publication Date
GB1577868A true GB1577868A (en) 1980-10-29

Family

ID=12634441

Family Applications (1)

Application Number Title Priority Date Filing Date
GB14869/77A Expired GB1577868A (en) 1976-04-16 1977-04-07 Agent for protecting against renal failure

Country Status (5)

Country Link
US (1) US4122171A (enExample)
JP (1) JPS52128232A (enExample)
DE (1) DE2716535C3 (enExample)
FR (1) FR2347927A1 (enExample)
GB (1) GB1577868A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975441A (en) * 1988-03-23 1990-12-04 Unilever Patent Holdings B.V. Lactams, their synthesis and use in cosmetic compositions

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5557598A (en) * 1978-10-25 1980-04-28 Meiji Seika Kaisha Ltd Salt of amino glycoside antibiotic substance having reduced toxicity
DE4022479C3 (de) * 1990-07-14 1996-11-21 Hella Kg Hueck & Co Verzögerungsschaltung für die Innenraumbeleuchtung eines Kraftfahrzeuges
US7345018B2 (en) 2002-04-25 2008-03-18 Reception Aps Method of treating side effects induced by therapeutic agents
WO2006037069A1 (en) * 2004-09-28 2006-04-06 Allergan, Inc. Compositions comprising nb-dnj, ne-dnj or d-glucaro-delta-lactam and their uses for the treatment of pain and other neurological conditions
US20100260863A1 (en) * 2007-12-11 2010-10-14 Monroe Stephen H Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962429A (en) * 1973-08-01 1976-06-08 Chugai Seiyaku Kabushiki Kaisha Method for reducing side effects of aminoglycoside antibiotics and composition therefor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975441A (en) * 1988-03-23 1990-12-04 Unilever Patent Holdings B.V. Lactams, their synthesis and use in cosmetic compositions

Also Published As

Publication number Publication date
DE2716535A1 (de) 1977-10-20
JPS61324B2 (enExample) 1986-01-08
JPS52128232A (en) 1977-10-27
US4122171A (en) 1978-10-24
FR2347927A1 (fr) 1977-11-10
DE2716535C3 (de) 1979-11-08
FR2347927B1 (enExample) 1979-03-02
DE2716535B2 (de) 1979-03-15

Similar Documents

Publication Publication Date Title
Weinstein et al. Gentamicin, 1 a new antibiotic complex from Micromonospora
US6908905B2 (en) N-substituted pyrazole-O-glycoside derivatives and therapeutic agent for diabetes containing the same
DE2602193C2 (de) (1R)-1-(L-Alanylamino)-ethylphosphonsäure und deren pharmakologisch verträgliche Salze, deren Herstellung und Arzneimittel auf der Basis dieser Verbindung bzw. von deren Salzen
DE2437160C3 (de) 1-N-Äthylsisomicin und Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
AU734748B2 (en) Bismuth salts of antibiotics of the moenomycin group, processes for their preparation, their use and pharmaceuticals comprising such salts
US4122171A (en) Agent for protecting against renal failure
US4053591A (en) 5-deoxy-4,6-di-o-(aminoglycosyl)-1,3-diaminocyclitols, methods for their manufacture, method for their use as antibacterial agents and compositions useful therefor
DE2724597A1 (de) Verfahren zur herstellung von kanamycin c und dessen desoxyderivaten, die so hergestellten derivate und mittel, die diese derivate enthalten
DE69233529T2 (de) Orale antibakterielle Zusammensetzungen und Verfahren zur Verbesserung der Resorption von Penem-oder Carbapenem-Antibiotika im Magen-Darm-Trakt
DE2618009B2 (de) l-N-(a-Hydroxy-eo-aminoacyl)- derivate des 3'-Deoxykanamycin A und diese enthaltende Arzneimittel
Acred Therapeutic and kinetic properties of ceftazidime in animals
US4125610A (en) Antibacterial compositions
EP1197214A1 (en) Medicinal compositions for preventing or treating diarrhea
DE2819372A1 (de) 3,5-disubstituierte 1h-1,2,4-triazole und verfahren zu ihrer herstellung
WO1993007864A1 (en) Use of suramine and related compounds as contraceptive agents
Kreft et al. Experimental studies on the nephrotoxicity of amphotericin B in rats
EP0238207B1 (en) Bactericidal mixtures
DE2521922A1 (de) Pharmazeutisches mittel
US4062964A (en) Antifertility-combinations
Scheife et al. Bacampicillin hydrochloride: chemistry, pharmacology, and clinical use
IL44618A (en) Pharmaceutical compositions comprising mixed salts of polysulfuric esters of naturally occurring glycopeptides with metals and organic bases
US3783159A (en) Pharmaceutical compositions containing kanamycin embonate
DE68906792T2 (de) Eregolin abkoemmlinge mit anti-emesis wirkung.
DE3901508C2 (de) Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
Marre et al. Animal studies on the reduction of aminoglycoside-induced nephrotoxicity by D-glucaro-1, 5-lactam

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940407